nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP3A7—Sorafenib—thyroid cancer	0.114	0.178	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.114	0.178	CbGbCtD
Cilostazol—CYP3A5—Sorafenib—thyroid cancer	0.0853	0.134	CbGbCtD
Cilostazol—CYP2C19—Sorafenib—thyroid cancer	0.0688	0.108	CbGbCtD
Cilostazol—CYP1A2—Sorafenib—thyroid cancer	0.0635	0.0996	CbGbCtD
Cilostazol—CYP3A4—Vandetanib—thyroid cancer	0.0552	0.0865	CbGbCtD
Cilostazol—CYP2D6—Sorafenib—thyroid cancer	0.0523	0.082	CbGbCtD
Cilostazol—CYP3A4—Sorafenib—thyroid cancer	0.0333	0.0522	CbGbCtD
Cilostazol—CYP2D6—Doxorubicin—thyroid cancer	0.0318	0.0498	CbGbCtD
Cilostazol—CYP3A4—Doxorubicin—thyroid cancer	0.0202	0.0316	CbGbCtD
Cilostazol—Creatinine increased—Doxorubicin—thyroid cancer	0.000738	0.00204	CcSEcCtD
Cilostazol—Bone pain—Doxorubicin—thyroid cancer	0.000733	0.00203	CcSEcCtD
Cilostazol—Cystitis—Epirubicin—thyroid cancer	0.000733	0.00202	CcSEcCtD
Cilostazol—Colitis—Epirubicin—thyroid cancer	0.000729	0.00201	CcSEcCtD
Cilostazol—Infection—Sorafenib—thyroid cancer	0.000728	0.00201	CcSEcCtD
Cilostazol—Shock—Sorafenib—thyroid cancer	0.000721	0.00199	CcSEcCtD
Cilostazol—Fluid retention—Epirubicin—thyroid cancer	0.00072	0.00199	CcSEcCtD
Cilostazol—Nervous system disorder—Sorafenib—thyroid cancer	0.000718	0.00198	CcSEcCtD
Cilostazol—Dizziness—Vandetanib—thyroid cancer	0.000718	0.00198	CcSEcCtD
Cilostazol—Thrombocytopenia—Sorafenib—thyroid cancer	0.000717	0.00198	CcSEcCtD
Cilostazol—Blood urea increased—Epirubicin—thyroid cancer	0.000716	0.00198	CcSEcCtD
Cilostazol—Vaginal infection—Epirubicin—thyroid cancer	0.000716	0.00198	CcSEcCtD
Cilostazol—Blood uric acid increased—Doxorubicin—thyroid cancer	0.000715	0.00198	CcSEcCtD
Cilostazol—Aplastic anaemia—Epirubicin—thyroid cancer	0.000712	0.00197	CcSEcCtD
Cilostazol—Skin disorder—Sorafenib—thyroid cancer	0.000712	0.00197	CcSEcCtD
Cilostazol—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.000702	0.00194	CcSEcCtD
Cilostazol—Vaginal inflammation—Doxorubicin—thyroid cancer	0.000702	0.00194	CcSEcCtD
Cilostazol—Anorexia—Sorafenib—thyroid cancer	0.000698	0.00193	CcSEcCtD
Cilostazol—Cramps of lower extremities—Epirubicin—thyroid cancer	0.000697	0.00193	CcSEcCtD
Cilostazol—Oesophagitis—Epirubicin—thyroid cancer	0.000693	0.00192	CcSEcCtD
Cilostazol—Vomiting—Vandetanib—thyroid cancer	0.000691	0.00191	CcSEcCtD
Cilostazol—Ecchymosis—Epirubicin—thyroid cancer	0.000686	0.0019	CcSEcCtD
Cilostazol—Bladder pain—Epirubicin—thyroid cancer	0.000686	0.0019	CcSEcCtD
Cilostazol—Cystitis noninfective—Doxorubicin—thyroid cancer	0.000686	0.00189	CcSEcCtD
Cilostazol—Melaena—Doxorubicin—thyroid cancer	0.000686	0.00189	CcSEcCtD
Cilostazol—Rash—Vandetanib—thyroid cancer	0.000685	0.00189	CcSEcCtD
Cilostazol—Dermatitis—Vandetanib—thyroid cancer	0.000684	0.00189	CcSEcCtD
Cilostazol—Headache—Vandetanib—thyroid cancer	0.00068	0.00188	CcSEcCtD
Cilostazol—Cystitis—Doxorubicin—thyroid cancer	0.000678	0.00187	CcSEcCtD
Cilostazol—Colitis—Doxorubicin—thyroid cancer	0.000674	0.00186	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000667	0.00184	CcSEcCtD
Cilostazol—Fluid retention—Doxorubicin—thyroid cancer	0.000667	0.00184	CcSEcCtD
Cilostazol—Blood urea increased—Doxorubicin—thyroid cancer	0.000663	0.00183	CcSEcCtD
Cilostazol—Vaginal infection—Doxorubicin—thyroid cancer	0.000663	0.00183	CcSEcCtD
Cilostazol—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000659	0.00182	CcSEcCtD
Cilostazol—Dyspnoea—Sorafenib—thyroid cancer	0.000653	0.0018	CcSEcCtD
Cilostazol—Nausea—Vandetanib—thyroid cancer	0.000645	0.00178	CcSEcCtD
Cilostazol—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000645	0.00178	CcSEcCtD
Cilostazol—Dyspepsia—Sorafenib—thyroid cancer	0.000645	0.00178	CcSEcCtD
Cilostazol—Oesophagitis—Doxorubicin—thyroid cancer	0.000642	0.00177	CcSEcCtD
Cilostazol—Decreased appetite—Sorafenib—thyroid cancer	0.000637	0.00176	CcSEcCtD
Cilostazol—Ecchymosis—Doxorubicin—thyroid cancer	0.000635	0.00175	CcSEcCtD
Cilostazol—Bladder pain—Doxorubicin—thyroid cancer	0.000635	0.00175	CcSEcCtD
Cilostazol—Diabetes mellitus—Epirubicin—thyroid cancer	0.000633	0.00175	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000632	0.00175	CcSEcCtD
Cilostazol—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00063	0.00174	CcSEcCtD
Cilostazol—Pain—Sorafenib—thyroid cancer	0.000626	0.00173	CcSEcCtD
Cilostazol—Vascular purpura—Epirubicin—thyroid cancer	0.000616	0.0017	CcSEcCtD
Cilostazol—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000607	0.00168	CcSEcCtD
Cilostazol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000599	0.00166	CcSEcCtD
Cilostazol—Hot flush—Epirubicin—thyroid cancer	0.000589	0.00163	CcSEcCtD
Cilostazol—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000586	0.00162	CcSEcCtD
Cilostazol—Menopausal symptoms—Epirubicin—thyroid cancer	0.000584	0.00161	CcSEcCtD
Cilostazol—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000583	0.00161	CcSEcCtD
Cilostazol—Urticaria—Sorafenib—thyroid cancer	0.000582	0.00161	CcSEcCtD
Cilostazol—Body temperature increased—Sorafenib—thyroid cancer	0.000579	0.0016	CcSEcCtD
Cilostazol—Abdominal pain—Sorafenib—thyroid cancer	0.000579	0.0016	CcSEcCtD
Cilostazol—Purpura—Epirubicin—thyroid cancer	0.000572	0.00158	CcSEcCtD
Cilostazol—Vascular purpura—Doxorubicin—thyroid cancer	0.00057	0.00157	CcSEcCtD
Cilostazol—Cardiac failure—Epirubicin—thyroid cancer	0.000564	0.00156	CcSEcCtD
Cilostazol—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000562	0.00155	CcSEcCtD
Cilostazol—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000562	0.00155	CcSEcCtD
Cilostazol—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000551	0.00152	CcSEcCtD
Cilostazol—Diplopia—Epirubicin—thyroid cancer	0.000551	0.00152	CcSEcCtD
Cilostazol—Hot flush—Doxorubicin—thyroid cancer	0.000545	0.00151	CcSEcCtD
Cilostazol—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00054	0.00149	CcSEcCtD
Cilostazol—Face oedema—Epirubicin—thyroid cancer	0.000532	0.00147	CcSEcCtD
Cilostazol—Purpura—Doxorubicin—thyroid cancer	0.000529	0.00146	CcSEcCtD
Cilostazol—Asthenia—Sorafenib—thyroid cancer	0.000526	0.00145	CcSEcCtD
Cilostazol—Cardiac arrest—Epirubicin—thyroid cancer	0.000524	0.00145	CcSEcCtD
Cilostazol—Cardiac failure—Doxorubicin—thyroid cancer	0.000522	0.00144	CcSEcCtD
Cilostazol—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00052	0.00144	CcSEcCtD
Cilostazol—Pruritus—Sorafenib—thyroid cancer	0.000518	0.00143	CcSEcCtD
Cilostazol—Blood creatinine increased—Epirubicin—thyroid cancer	0.000516	0.00143	CcSEcCtD
Cilostazol—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00051	0.00141	CcSEcCtD
Cilostazol—Diplopia—Doxorubicin—thyroid cancer	0.00051	0.00141	CcSEcCtD
Cilostazol—Liver function test abnormal—Epirubicin—thyroid cancer	0.000509	0.00141	CcSEcCtD
Cilostazol—Dry skin—Epirubicin—thyroid cancer	0.000505	0.0014	CcSEcCtD
Cilostazol—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000503	0.00139	CcSEcCtD
Cilostazol—Diarrhoea—Sorafenib—thyroid cancer	0.000501	0.00138	CcSEcCtD
Cilostazol—Face oedema—Doxorubicin—thyroid cancer	0.000492	0.00136	CcSEcCtD
Cilostazol—Gastritis—Epirubicin—thyroid cancer	0.000488	0.00135	CcSEcCtD
Cilostazol—Cardiac arrest—Doxorubicin—thyroid cancer	0.000485	0.00134	CcSEcCtD
Cilostazol—Dizziness—Sorafenib—thyroid cancer	0.000484	0.00134	CcSEcCtD
Cilostazol—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000478	0.00132	CcSEcCtD
Cilostazol—Asthma—Epirubicin—thyroid cancer	0.000476	0.00132	CcSEcCtD
Cilostazol—Influenza—Epirubicin—thyroid cancer	0.000476	0.00132	CcSEcCtD
Cilostazol—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000471	0.0013	CcSEcCtD
Cilostazol—Dry skin—Doxorubicin—thyroid cancer	0.000467	0.00129	CcSEcCtD
Cilostazol—Vomiting—Sorafenib—thyroid cancer	0.000466	0.00129	CcSEcCtD
Cilostazol—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000466	0.00129	CcSEcCtD
Cilostazol—Angina pectoris—Epirubicin—thyroid cancer	0.000464	0.00128	CcSEcCtD
Cilostazol—Rash—Sorafenib—thyroid cancer	0.000462	0.00128	CcSEcCtD
Cilostazol—Dermatitis—Sorafenib—thyroid cancer	0.000461	0.00128	CcSEcCtD
Cilostazol—Headache—Sorafenib—thyroid cancer	0.000459	0.00127	CcSEcCtD
Cilostazol—Bronchitis—Epirubicin—thyroid cancer	0.000458	0.00127	CcSEcCtD
Cilostazol—Pancytopenia—Epirubicin—thyroid cancer	0.000452	0.00125	CcSEcCtD
Cilostazol—Gastritis—Doxorubicin—thyroid cancer	0.000451	0.00125	CcSEcCtD
Cilostazol—Asthma—Doxorubicin—thyroid cancer	0.000441	0.00122	CcSEcCtD
Cilostazol—Influenza—Doxorubicin—thyroid cancer	0.000441	0.00122	CcSEcCtD
Cilostazol—Pollakiuria—Epirubicin—thyroid cancer	0.00044	0.00122	CcSEcCtD
Cilostazol—Nausea—Sorafenib—thyroid cancer	0.000435	0.0012	CcSEcCtD
Cilostazol—Angina pectoris—Doxorubicin—thyroid cancer	0.000429	0.00119	CcSEcCtD
Cilostazol—Pneumonia—Epirubicin—thyroid cancer	0.000427	0.00118	CcSEcCtD
Cilostazol—Bronchitis—Doxorubicin—thyroid cancer	0.000424	0.00117	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000421	0.00116	CcSEcCtD
Cilostazol—Pancytopenia—Doxorubicin—thyroid cancer	0.000418	0.00116	CcSEcCtD
Cilostazol—Jaundice—Epirubicin—thyroid cancer	0.000414	0.00114	CcSEcCtD
Cilostazol—Conjunctivitis—Epirubicin—thyroid cancer	0.000413	0.00114	CcSEcCtD
Cilostazol—Urinary tract infection—Epirubicin—thyroid cancer	0.000413	0.00114	CcSEcCtD
Cilostazol—Pollakiuria—Doxorubicin—thyroid cancer	0.000407	0.00112	CcSEcCtD
Cilostazol—Haematuria—Epirubicin—thyroid cancer	0.000405	0.00112	CcSEcCtD
Cilostazol—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000401	0.00111	CcSEcCtD
Cilostazol—Epistaxis—Epirubicin—thyroid cancer	0.0004	0.00111	CcSEcCtD
Cilostazol—Sinusitis—Epirubicin—thyroid cancer	0.000398	0.0011	CcSEcCtD
Cilostazol—Agranulocytosis—Epirubicin—thyroid cancer	0.000396	0.00109	CcSEcCtD
Cilostazol—Pneumonia—Doxorubicin—thyroid cancer	0.000395	0.00109	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000389	0.00108	CcSEcCtD
Cilostazol—Haemoglobin—Epirubicin—thyroid cancer	0.000383	0.00106	CcSEcCtD
Cilostazol—Jaundice—Doxorubicin—thyroid cancer	0.000383	0.00106	CcSEcCtD
Cilostazol—Rhinitis—Epirubicin—thyroid cancer	0.000382	0.00106	CcSEcCtD
Cilostazol—Conjunctivitis—Doxorubicin—thyroid cancer	0.000382	0.00105	CcSEcCtD
Cilostazol—Urinary tract infection—Doxorubicin—thyroid cancer	0.000382	0.00105	CcSEcCtD
Cilostazol—Haemorrhage—Epirubicin—thyroid cancer	0.000381	0.00105	CcSEcCtD
Cilostazol—Hypoaesthesia—Epirubicin—thyroid cancer	0.000379	0.00105	CcSEcCtD
Cilostazol—Pharyngitis—Epirubicin—thyroid cancer	0.000378	0.00104	CcSEcCtD
Cilostazol—Oedema peripheral—Epirubicin—thyroid cancer	0.000375	0.00104	CcSEcCtD
Cilostazol—Haematuria—Doxorubicin—thyroid cancer	0.000375	0.00103	CcSEcCtD
Cilostazol—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000371	0.00103	CcSEcCtD
Cilostazol—Epistaxis—Doxorubicin—thyroid cancer	0.00037	0.00102	CcSEcCtD
Cilostazol—Sinusitis—Doxorubicin—thyroid cancer	0.000369	0.00102	CcSEcCtD
Cilostazol—Agranulocytosis—Doxorubicin—thyroid cancer	0.000367	0.00101	CcSEcCtD
Cilostazol—Erythema multiforme—Epirubicin—thyroid cancer	0.00036	0.000996	CcSEcCtD
Cilostazol—Tinnitus—Epirubicin—thyroid cancer	0.000355	0.000982	CcSEcCtD
Cilostazol—Haemoglobin—Doxorubicin—thyroid cancer	0.000354	0.000979	CcSEcCtD
Cilostazol—Cardiac disorder—Epirubicin—thyroid cancer	0.000354	0.000977	CcSEcCtD
Cilostazol—Rhinitis—Doxorubicin—thyroid cancer	0.000354	0.000977	CcSEcCtD
Cilostazol—Haemorrhage—Doxorubicin—thyroid cancer	0.000353	0.000974	CcSEcCtD
Cilostazol—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000351	0.000969	CcSEcCtD
Cilostazol—Pharyngitis—Doxorubicin—thyroid cancer	0.00035	0.000967	CcSEcCtD
Cilostazol—Oedema peripheral—Doxorubicin—thyroid cancer	0.000347	0.00096	CcSEcCtD
Cilostazol—Angiopathy—Epirubicin—thyroid cancer	0.000346	0.000955	CcSEcCtD
Cilostazol—Mediastinal disorder—Epirubicin—thyroid cancer	0.000343	0.000949	CcSEcCtD
Cilostazol—Chills—Epirubicin—thyroid cancer	0.000342	0.000945	CcSEcCtD
Cilostazol—Erythema multiforme—Doxorubicin—thyroid cancer	0.000333	0.000921	CcSEcCtD
Cilostazol—Tinnitus—Doxorubicin—thyroid cancer	0.000329	0.000908	CcSEcCtD
Cilostazol—Cardiac disorder—Doxorubicin—thyroid cancer	0.000327	0.000904	CcSEcCtD
Cilostazol—Flatulence—Epirubicin—thyroid cancer	0.000327	0.000903	CcSEcCtD
Cilostazol—Back pain—Epirubicin—thyroid cancer	0.000321	0.000887	CcSEcCtD
Cilostazol—Angiopathy—Doxorubicin—thyroid cancer	0.00032	0.000884	CcSEcCtD
Cilostazol—Muscle spasms—Epirubicin—thyroid cancer	0.000319	0.000881	CcSEcCtD
Cilostazol—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000318	0.000878	CcSEcCtD
Cilostazol—Chills—Doxorubicin—thyroid cancer	0.000316	0.000874	CcSEcCtD
Cilostazol—Ill-defined disorder—Epirubicin—thyroid cancer	0.000308	0.00085	CcSEcCtD
Cilostazol—Anaemia—Epirubicin—thyroid cancer	0.000307	0.000847	CcSEcCtD
Cilostazol—Flatulence—Doxorubicin—thyroid cancer	0.000302	0.000836	CcSEcCtD
Cilostazol—Malaise—Epirubicin—thyroid cancer	0.000299	0.000827	CcSEcCtD
Cilostazol—Vertigo—Epirubicin—thyroid cancer	0.000298	0.000823	CcSEcCtD
Cilostazol—Syncope—Epirubicin—thyroid cancer	0.000297	0.000822	CcSEcCtD
Cilostazol—Leukopenia—Epirubicin—thyroid cancer	0.000297	0.00082	CcSEcCtD
Cilostazol—Back pain—Doxorubicin—thyroid cancer	0.000297	0.00082	CcSEcCtD
Cilostazol—Muscle spasms—Doxorubicin—thyroid cancer	0.000295	0.000815	CcSEcCtD
Cilostazol—Palpitations—Epirubicin—thyroid cancer	0.000293	0.00081	CcSEcCtD
Cilostazol—Loss of consciousness—Epirubicin—thyroid cancer	0.000292	0.000806	CcSEcCtD
Cilostazol—Cough—Epirubicin—thyroid cancer	0.000289	0.0008	CcSEcCtD
Cilostazol—Hypertension—Epirubicin—thyroid cancer	0.000286	0.000791	CcSEcCtD
Cilostazol—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000285	0.000787	CcSEcCtD
Cilostazol—Anaemia—Doxorubicin—thyroid cancer	0.000284	0.000784	CcSEcCtD
Cilostazol—Myalgia—Epirubicin—thyroid cancer	0.000282	0.00078	CcSEcCtD
Cilostazol—Arthralgia—Epirubicin—thyroid cancer	0.000282	0.00078	CcSEcCtD
Cilostazol—Chest pain—Epirubicin—thyroid cancer	0.000282	0.00078	CcSEcCtD
Cilostazol—Anxiety—Epirubicin—thyroid cancer	0.000281	0.000778	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00028	0.000775	CcSEcCtD
Cilostazol—Discomfort—Epirubicin—thyroid cancer	0.000279	0.000771	CcSEcCtD
Cilostazol—Malaise—Doxorubicin—thyroid cancer	0.000277	0.000765	CcSEcCtD
Cilostazol—Vertigo—Doxorubicin—thyroid cancer	0.000276	0.000762	CcSEcCtD
Cilostazol—Syncope—Doxorubicin—thyroid cancer	0.000275	0.000761	CcSEcCtD
Cilostazol—Leukopenia—Doxorubicin—thyroid cancer	0.000275	0.000759	CcSEcCtD
Cilostazol—Palpitations—Doxorubicin—thyroid cancer	0.000271	0.000749	CcSEcCtD
Cilostazol—Oedema—Epirubicin—thyroid cancer	0.000271	0.000748	CcSEcCtD
Cilostazol—Loss of consciousness—Doxorubicin—thyroid cancer	0.00027	0.000745	CcSEcCtD
Cilostazol—Infection—Epirubicin—thyroid cancer	0.000269	0.000743	CcSEcCtD
Cilostazol—Cough—Doxorubicin—thyroid cancer	0.000268	0.00074	CcSEcCtD
Cilostazol—Shock—Epirubicin—thyroid cancer	0.000266	0.000736	CcSEcCtD
Cilostazol—Nervous system disorder—Epirubicin—thyroid cancer	0.000266	0.000734	CcSEcCtD
Cilostazol—Thrombocytopenia—Epirubicin—thyroid cancer	0.000265	0.000732	CcSEcCtD
Cilostazol—Hypertension—Doxorubicin—thyroid cancer	0.000265	0.000732	CcSEcCtD
Cilostazol—Tachycardia—Epirubicin—thyroid cancer	0.000264	0.00073	CcSEcCtD
Cilostazol—Skin disorder—Epirubicin—thyroid cancer	0.000263	0.000727	CcSEcCtD
Cilostazol—Chest pain—Doxorubicin—thyroid cancer	0.000261	0.000722	CcSEcCtD
Cilostazol—Myalgia—Doxorubicin—thyroid cancer	0.000261	0.000722	CcSEcCtD
Cilostazol—Arthralgia—Doxorubicin—thyroid cancer	0.000261	0.000722	CcSEcCtD
Cilostazol—Anxiety—Doxorubicin—thyroid cancer	0.00026	0.00072	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00026	0.000717	CcSEcCtD
Cilostazol—Discomfort—Doxorubicin—thyroid cancer	0.000258	0.000713	CcSEcCtD
Cilostazol—Anorexia—Epirubicin—thyroid cancer	0.000258	0.000713	CcSEcCtD
Cilostazol—Hypotension—Epirubicin—thyroid cancer	0.000253	0.000699	CcSEcCtD
Cilostazol—Oedema—Doxorubicin—thyroid cancer	0.000251	0.000692	CcSEcCtD
Cilostazol—Infection—Doxorubicin—thyroid cancer	0.000249	0.000688	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000247	0.000682	CcSEcCtD
Cilostazol—Shock—Doxorubicin—thyroid cancer	0.000246	0.000681	CcSEcCtD
Cilostazol—Nervous system disorder—Doxorubicin—thyroid cancer	0.000246	0.000679	CcSEcCtD
Cilostazol—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000245	0.000678	CcSEcCtD
Cilostazol—Insomnia—Epirubicin—thyroid cancer	0.000245	0.000677	CcSEcCtD
Cilostazol—Tachycardia—Doxorubicin—thyroid cancer	0.000244	0.000676	CcSEcCtD
Cilostazol—Skin disorder—Doxorubicin—thyroid cancer	0.000243	0.000672	CcSEcCtD
Cilostazol—Paraesthesia—Epirubicin—thyroid cancer	0.000243	0.000672	CcSEcCtD
Cilostazol—Dyspnoea—Epirubicin—thyroid cancer	0.000241	0.000667	CcSEcCtD
Cilostazol—Anorexia—Doxorubicin—thyroid cancer	0.000239	0.00066	CcSEcCtD
Cilostazol—Dyspepsia—Epirubicin—thyroid cancer	0.000238	0.000658	CcSEcCtD
Cilostazol—Decreased appetite—Epirubicin—thyroid cancer	0.000235	0.00065	CcSEcCtD
Cilostazol—Hypotension—Doxorubicin—thyroid cancer	0.000234	0.000647	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000234	0.000646	CcSEcCtD
Cilostazol—Pain—Epirubicin—thyroid cancer	0.000232	0.00064	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000228	0.000631	CcSEcCtD
Cilostazol—Insomnia—Doxorubicin—thyroid cancer	0.000227	0.000626	CcSEcCtD
Cilostazol—Paraesthesia—Doxorubicin—thyroid cancer	0.000225	0.000621	CcSEcCtD
Cilostazol—Dyspnoea—Doxorubicin—thyroid cancer	0.000223	0.000617	CcSEcCtD
Cilostazol—Feeling abnormal—Epirubicin—thyroid cancer	0.000223	0.000616	CcSEcCtD
Cilostazol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000221	0.000612	CcSEcCtD
Cilostazol—Dyspepsia—Doxorubicin—thyroid cancer	0.000221	0.000609	CcSEcCtD
Cilostazol—Decreased appetite—Doxorubicin—thyroid cancer	0.000218	0.000602	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000216	0.000598	CcSEcCtD
Cilostazol—Urticaria—Epirubicin—thyroid cancer	0.000215	0.000594	CcSEcCtD
Cilostazol—Pain—Doxorubicin—thyroid cancer	0.000214	0.000592	CcSEcCtD
Cilostazol—Abdominal pain—Epirubicin—thyroid cancer	0.000214	0.000591	CcSEcCtD
Cilostazol—Body temperature increased—Epirubicin—thyroid cancer	0.000214	0.000591	CcSEcCtD
Cilostazol—Feeling abnormal—Doxorubicin—thyroid cancer	0.000206	0.00057	CcSEcCtD
Cilostazol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000205	0.000566	CcSEcCtD
Cilostazol—Urticaria—Doxorubicin—thyroid cancer	0.000199	0.00055	CcSEcCtD
Cilostazol—Body temperature increased—Doxorubicin—thyroid cancer	0.000198	0.000547	CcSEcCtD
Cilostazol—Abdominal pain—Doxorubicin—thyroid cancer	0.000198	0.000547	CcSEcCtD
Cilostazol—Asthenia—Epirubicin—thyroid cancer	0.000194	0.000537	CcSEcCtD
Cilostazol—Pruritus—Epirubicin—thyroid cancer	0.000192	0.000529	CcSEcCtD
Cilostazol—Diarrhoea—Epirubicin—thyroid cancer	0.000185	0.000512	CcSEcCtD
Cilostazol—Asthenia—Doxorubicin—thyroid cancer	0.00018	0.000497	CcSEcCtD
Cilostazol—Dizziness—Epirubicin—thyroid cancer	0.000179	0.000495	CcSEcCtD
Cilostazol—Pruritus—Doxorubicin—thyroid cancer	0.000177	0.00049	CcSEcCtD
Cilostazol—Vomiting—Epirubicin—thyroid cancer	0.000172	0.000476	CcSEcCtD
Cilostazol—Diarrhoea—Doxorubicin—thyroid cancer	0.000171	0.000474	CcSEcCtD
Cilostazol—Rash—Epirubicin—thyroid cancer	0.000171	0.000472	CcSEcCtD
Cilostazol—Dermatitis—Epirubicin—thyroid cancer	0.000171	0.000471	CcSEcCtD
Cilostazol—Headache—Epirubicin—thyroid cancer	0.00017	0.000469	CcSEcCtD
Cilostazol—Dizziness—Doxorubicin—thyroid cancer	0.000166	0.000458	CcSEcCtD
Cilostazol—Nausea—Epirubicin—thyroid cancer	0.000161	0.000444	CcSEcCtD
Cilostazol—Vomiting—Doxorubicin—thyroid cancer	0.000159	0.00044	CcSEcCtD
Cilostazol—Rash—Doxorubicin—thyroid cancer	0.000158	0.000436	CcSEcCtD
Cilostazol—Dermatitis—Doxorubicin—thyroid cancer	0.000158	0.000436	CcSEcCtD
Cilostazol—Headache—Doxorubicin—thyroid cancer	0.000157	0.000434	CcSEcCtD
Cilostazol—Nausea—Doxorubicin—thyroid cancer	0.000149	0.000411	CcSEcCtD
